MedPath

Palmitoylethanolamide in the treatment of major depressio

Not Applicable
Recruiting
Conditions
Major Depressive Disorder.
Major Depressive Disorder
Registration Number
IRCT201702181556N97
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

presence of Major Depressive Disorder based on DSM-5 criteria; baseline Hamilton Depression Rating Scale (HAM-D) (17-item) score of at least 19. Exclusion criteria: presence of psychosis, any other diagnosis in axis I and II; receiving psychotropic medications; receiving any antidepressants during past one month or ECT during past two months; presence of hypothyroidism or cardiovascular problems, pregnancy or nursing women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of depression. Timepoint: Baseline and weeks 2,4 and 6. Method of measurement: by Hamiltion Depression Rating Scale 17-Item.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath